176 related articles for article (PubMed ID: 38594619)
1. Targeting Mitochondrial Complex I Deficiency in MPP
Li H; Zhang J; Shen Y; Ye Y; Jiang Q; Chen L; Sun B; Chen Z; Shen L; Fang H; Yang J; Gu H
Biol Proced Online; 2024 Apr; 26(1):9. PubMed ID: 38594619
[TBL] [Abstract][Full Text] [Related]
2. Gene therapy of yeast NDI1 on mitochondrial complex I dysfunction in rotenone-induced Parkinson's disease models in vitro and vivo.
Li H; Sun B; Huang Y; Zhang J; Xu X; Shen Y; Chen Z; Yang J; Shen L; Hu Y; Gu H
Mol Med; 2022 Mar; 28(1):29. PubMed ID: 35255803
[TBL] [Abstract][Full Text] [Related]
3. Obligatory role for complex I inhibition in the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Richardson JR; Caudle WM; Guillot TS; Watson JL; Nakamaru-Ogiso E; Seo BB; Sherer TB; Greenamyre JT; Yagi T; Matsuno-Yagi A; Miller GW
Toxicol Sci; 2007 Jan; 95(1):196-204. PubMed ID: 17038483
[TBL] [Abstract][Full Text] [Related]
4. In vivo complementation of complex I by the yeast Ndi1 enzyme. Possible application for treatment of Parkinson disease.
Seo BB; Nakamaru-Ogiso E; Flotte TR; Matsuno-Yagi A; Yagi T
J Biol Chem; 2006 May; 281(20):14250-5. PubMed ID: 16543240
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective Effects of the DPP4 Inhibitor Vildagliptin in In Vivo and In Vitro Models of Parkinson's Disease.
Pariyar R; Bastola T; Lee DH; Seo J
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216503
[TBL] [Abstract][Full Text] [Related]
6. Hyperbaric Oxygen Therapy Improves Parkinson's Disease by Promoting Mitochondrial Biogenesis via the SIRT-1/PGC-1α Pathway.
Hsu HT; Yang YL; Chang WH; Fang WY; Huang SH; Chou SH; Lo YC
Biomolecules; 2022 Apr; 12(5):. PubMed ID: 35625589
[TBL] [Abstract][Full Text] [Related]
7. Artemisia Leaf Extract protects against neuron toxicity by TRPML1 activation and promoting autophagy/mitophagy clearance in both in vitro and in vivo models of MPP+/MPTP-induced Parkinson's disease.
Wu LK; Agarwal S; Kuo CH; Kung YL; Day CH; Lin PY; Lin SZ; Hsieh DJ; Huang CY; Chiang CY
Phytomedicine; 2022 Sep; 104():154250. PubMed ID: 35752074
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of miR-124 in MPTP-treated mouse model of Parkinson's disease and MPP iodide-treated MN9D cells modulates the expression of the calpain/cdk5 pathway proteins.
Kanagaraj N; Beiping H; Dheen ST; Tay SS
Neuroscience; 2014 Jul; 272():167-79. PubMed ID: 24792712
[TBL] [Abstract][Full Text] [Related]
9. 2-Aminoethoxydiphenyl borate ameliorates mitochondrial dysfunctions in MPTP/MPP
Vaidya B; Polepalli M; Sharma SS; Singh JN
Mitochondrion; 2023 Mar; 69():95-103. PubMed ID: 36758857
[TBL] [Abstract][Full Text] [Related]
10. Vitexin protects dopaminergic neurons in MPTP-induced Parkinson's disease through PI3K/Akt signaling pathway.
Hu M; Li F; Wang W
Drug Des Devel Ther; 2018; 12():565-573. PubMed ID: 29588573
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective effects of Suhexiang Wan on the in vitro and in vivo models of Parkinson's disease.
Liu Q; Sang Heon K; Yung-Wei S; Sok Cheon P; Wonwoong L; Jongki H; Jaehwan J; Kyoung Sang C; Songhee J; Byung-Soo K
J Tradit Chin Med; 2019 Dec; 39(6):800-808. PubMed ID: 32186150
[TBL] [Abstract][Full Text] [Related]
12. Impaired CBS-H
Yuan YQ; Wang YL; Yuan BS; Yuan X; Hou XO; Bian JS; Liu CF; Hu LF
Brain Behav Immun; 2018 Jan; 67():77-90. PubMed ID: 28774789
[TBL] [Abstract][Full Text] [Related]
13. Modulation of mitochondrial phenotypes by endurance exercise contributes to neuroprotection against a MPTP-induced animal model of PD.
Jang Y; Kwon I; Song W; Cosio-Lima LM; Taylor S; Lee Y
Life Sci; 2018 Sep; 209():455-465. PubMed ID: 30144449
[TBL] [Abstract][Full Text] [Related]
14. MANF improves the MPP
Liu Y; Zhang J; Jiang M; Cai Q; Fang J; Jin L
Am J Transl Res; 2018; 10(5):1284-1294. PubMed ID: 29887945
[TBL] [Abstract][Full Text] [Related]
15. Amentoflavone protects dopaminergic neurons in MPTP-induced Parkinson's disease model mice through PI3K/Akt and ERK signaling pathways.
Cao Q; Qin L; Huang F; Wang X; Yang L; Shi H; Wu H; Zhang B; Chen Z; Wu X
Toxicol Appl Pharmacol; 2017 Mar; 319():80-90. PubMed ID: 28185818
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Potential Neuroprotective Effects of Vanillin Against MPP
Rani L; Ghosh B; Ahmad MH; Mondal AC
Mol Neurobiol; 2023 Aug; 60(8):4693-4715. PubMed ID: 37145378
[TBL] [Abstract][Full Text] [Related]
17. Genetic reduction of mitochondrial complex I function does not lead to loss of dopamine neurons in vivo.
Kim HW; Choi WS; Sorscher N; Park HJ; Tronche F; Palmiter RD; Xia Z
Neurobiol Aging; 2015 Sep; 36(9):2617-27. PubMed ID: 26070241
[TBL] [Abstract][Full Text] [Related]
18. Protection by the NDI1 gene against neurodegeneration in a rotenone rat model of Parkinson's disease.
Marella M; Seo BB; Nakamaru-Ogiso E; Greenamyre JT; Matsuno-Yagi A; Yagi T
PLoS One; 2008 Jan; 3(1):e1433. PubMed ID: 18197244
[TBL] [Abstract][Full Text] [Related]
19. Protective Role of rAAV-NDI1, Serotype 5, in an Acute MPTP Mouse Parkinson's Model.
Barber-Singh J; Seo BB; Matsuno-Yagi A; Yagi T
Parkinsons Dis; 2010 Dec; 2011():438370. PubMed ID: 21188192
[TBL] [Abstract][Full Text] [Related]
20. Triple herbal extract DA-9805 exerts a neuroprotective effect via amelioration of mitochondrial damage in experimental models of Parkinson's disease.
Jeong JS; Piao Y; Kang S; Son M; Kang YC; Du XF; Ryu J; Cho YW; Jiang HH; Oh MS; Hong SP; Oh YJ; Pak YK
Sci Rep; 2018 Oct; 8(1):15953. PubMed ID: 30374025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
